Allspring Global Investments Holdings LLC Cuts Stock Position in Hologic, Inc. $HOLX

Key Points

• Allspring Global Investments Holdings LLC cut its holdings by 99.5% in Hologic during Q4, selling 2,131,526 shares and leaving 10,210 shares worth $761,000 on its most recent 13F.
• Hologic missed the latest quarter's estimates, reporting $1.04 EPS vs. a $1.09 consensus and $1.05 billion in revenue (up 2.5% year-over-year but below the $1.07 billion estimate).
• Analyst sentiment is mainly cautious (two Buys vs. thirteen Holds) with an average target of $78.42; the stock trades near its 1‑year high, has a $16.97 billion market cap, and about 94.73% institutional ownership.

Allspring Global Investments Holdings LLC cut its holdings in shares of Hologic, Inc. (NASDAQ:HOLX - Free Report) by 99.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,210 shares of the medical equipment provider's stock after selling 2,131,526 shares during the period. Allspring Global Investments Holdings LLC's holdings in Hologic were worth $761,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Winnow Wealth LLC purchased a new stake in shares of Hologic during the third quarter worth approximately $26,000. Root Financial Partners LLC purchased a new stake in shares of Hologic during the third quarter worth approximately $27,000. SJS Investment Consulting Inc. increased its stake in shares of Hologic by 341.5% during the third quarter. SJS Investment Consulting Inc. now owns 468 shares of the medical equipment provider's stock worth $32,000 after buying an additional 362 shares during the period. Smartleaf Asset Management LLC increased its stake in shares of Hologic by 168.5% during the third quarter. Smartleaf Asset Management LLC now owns 494 shares of the medical equipment provider's stock worth $33,000 after buying an additional 310 shares during the period. Finally, Quent Capital LLC purchased a new stake in shares of Hologic during the third quarter worth approximately $39,000. 94.73% of the stock is currently owned by hedge funds and other institutional investors.

Hologic Price Performance

Shares of NASDAQ HOLX opened at $76.01 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 4.04 and a quick ratio of 3.32. The stock has a fifty day moving average price of $75.37 and a 200 day moving average price of $73.93. Hologic, Inc. has a 1-year low of $51.90 and a 1-year high of $76.07. The company has a market cap of $16.97 billion, a PE ratio of 31.67, a P/E/G ratio of 2.24 and a beta of 0.70.

Hologic (NASDAQ:HOLX - Get Free Report) last issued its quarterly earnings results on Thursday, January 29th. The medical equipment provider reported $1.04 earnings per share for the quarter, missing the consensus estimate of $1.09 by ($0.05). Hologic had a return on equity of 19.58% and a net margin of 13.18%.The company had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.07 billion. During the same period in the prior year, the business earned $0.87 earnings per share. Hologic's revenue for the quarter was up 2.5% compared to the same quarter last year. Sell-side analysts forecast that Hologic, Inc. will post 4.28 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Weiss Ratings restated a "hold (c)" rating on shares of Hologic in a research note on Wednesday, January 28th. Argus lowered shares of Hologic from a "buy" rating to a "hold" rating in a research note on Monday, January 12th. Finally, Evercore lowered shares of Hologic from an "outperform" rating to an "in-line" rating and dropped their price target for the company from $79.00 to $78.00 in a research note on Monday, January 5th. Two investment analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $78.42.

Hologic Profile

Hologic, Inc NASDAQ: HOLX is a global medical technology company specializing in women's health. Headquartered in Marlborough, Massachusetts, the company develops and manufactures diagnostic products, imaging systems and surgical solutions designed to detect, diagnose and treat diseases with a primary focus on breast and skeletal health, gynecological conditions and molecular diagnostics. Its product portfolio includes digital mammography systems, 3D mammography solutions, bone densitometry equipment and molecular assays for infectious disease and oncology applications.

Since its founding in 1985, Hologic has grown through both internal innovation and strategic acquisitions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.